top of page

 PORTFOLIO 

Supporting the development of tomorrow's vaccines

EVI's activities are diverse. We support and coordinate research into individual vaccine candidates, work across Europe to harmonise processes and protocols for vaccine development and strengthen the capacity for vaccine Research and Development in low- and middle-income countries.

Injectable and Oral drop_Our work_Regular.png
  • Translational R&D & Capacity strengthening 

  • Harmonisation 

  • Control Testing

  • Networking & Policy

Injectable and Oral drop_Our work_Hover.png
Nipah virus infection

CROSS-CUTTING ACTIVITIES

VACCINE R&D

EVI supports a diverse portfolio of pre-clinical, early clinical, and advanced clinical projects. We strategically use our resources to support and advance a wide range of vaccine candidates as well as cross-cutting activities.

Kindly notice that the PORTFOLIO of VACCINE CANDIDATES and CROSS-CUTTING ACTIVITIES is not visible via mobile devices. If applicable, please check again from your desktop browser.

VACCINE CANDIDATES

 

See below the vaccine candidate table targeting various stages in the development pipeline, and click on any of them to know more:

References:

* Candidates under selection for multi-stage approach

** Undisclosed combination

Grey colour indicates paused development

Lines indicate funding secured 

*** Approved vaccine assessed for alternative administration schedules

Discovery

Pre-clinical proof of concept

Clinical proof of concept

Development

Phase I

Phase IIa

Phase IIb

Phase III

Phase IV

Applied Vaccinology

CROSS-CUTTING ACTIVITES

 

We are committed to supporting vaccine development beyond individual vaccine candidates. We engage in initiatives aimed at creating harmonisation between stakeholders, promoting networking, developing innovative R&D solutions, and accessing vaccine infrastructure at the European and global level. 

See below the Cross-cutting Activities table, and click on any of them to know more about each project:

Active projects

Closed projects

If you have any questions regarding our portfolio of vaccines candidates or cross-cutting projects, emails us to contact.us@euvaccine.eu.

bottom of page